Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWALG.L Regulatory News (WALG)

  • There is currently no data for WALG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First day dealing

21 Dec 2006 09:00

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN THE UNITED STATES, CANADA, THE REPUBLIC OF IRELAND, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR AUSTRALIA, OR THEIR RESPECTIVE TERRITORIES OR POSSESSIONS

Walcom Group Limited

First day of trading

Walcom Group Limited ("Walcom" or "the Company"), the China based manufacturer and distributor of "clean" animal feed additives, announces the commencement of dealings in its common shares on the AIM Market of London Stock Exchange plc today, under the ticker code `WALG'.

Walcom's products are based on Cysteamine, a natural metabolite generated in animals' bodies which participates in animals' physiological `growth axis' to stimulate the animals' natural growth hormone level. The Company's feed additives improve the health of the animals, reduce mortality rates, shorten the time taken to reduce maturity, increase the protein content in animal food products, increase egg laying and reduce eggshell breakage and build resistance to disease. Walcom's feed additives are "non hormonal", "non antibiotic" and "non gene-altering".

Placing statisticsPlacing price per share 35p Number of new shares placed on behalf of the Company 4,491,735 Gross proceeds of the placing ‚£1.57 million

Estimated net proceeds of the placing available to the ‚£1.01 million Company

Market capitalisation at the placing price on admission ‚£22.72 million Number of shares in issue on admission 64,910,891

John East and Partners Limited is acting as Nominated Adviser and King & Shaxson Capital Limited is acting as Broker.

Francis Chi, Walcom Chief Executive commented:

"We have an extremely strong track record in developing "clean" animal feed additivesbacked byhighly motivatedresearch andmanagement teams.

"Our listing on AIM will raiseour international profileand will provide us with theextra working capital needed to increase our market penetration worldwide".

21 December 2006Enquiries:Walcom +852 2494 0133 Francis Chi, Chief Executive Officer Albert Wong, Chief Financial Officer John East and Partners +44 20 7628 2200 Jeffrey Coburn/Bidhi Bhoma

King & Shaxon Capital + 44 20 7426 5986 Nick Bealer Disclaimer

This announcement relating to the Company does not constitute or form part of, and should not be construed as an offer or invitation to sell or issue or any solicitation of any offer to purchase or subscribe for any securities in the Company in any jurisdiction. Neither this announcement, nor any part of it nor anything contained or referred to in it, nor the fact of its distribution, should form the basis of or be relied on in any connection with or act as an inducement in relation to a decision to purchase or subscribe for or enter into any contract or make and other commitment whatsoever in relation to any such securities. This announcement does not constitute a recommendation regarding the securities of the Company.

The information contained in this announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person or for the account of a US Person (within the meaning of Regulation S under the US securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted to Australia, Canada or Japan or the Republic of South Africa or to Canadian persons or to any Securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, or South African or Japanese securities law. The distribution of this Presentation in any other jurisdictions may be restricted by law and persons into whose possession this Presentation come should inform themselves about, and observe any such restrictions. The securities referred to are not being registered under the US Securities Act of 1933, as amended, or under the applicable securities laws of Canada, Australia, South Africa or Japan, and may not be offered or sold within Canada, Australia, South Africa or Japan to any national, resident or citizen of Canada, Australia, South Africa or Japan.

Forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt changes. Due to risks and uncertainties associated with the Company's business, actual results could differ materially from those projected or implied by management's forward-looking statements. These risks and uncertainties include, but are not limited to: changes and shifts in customer demand away from the Company's products to competitor products; the Company's ability to maintain and establish strategic relationships; the effects of competition; the risks inherent in the development and delivery of complex technologies; the Company's ability to attract, retain and motivate qualified personnel; the emergence of new markets for the Company's products and services; the Company's ability to compete in those markets based on timeliness and cost and market demand. In addition, new product introductions are subject to the risks and uncertainties that typically accompany development and delivery of complex products to the marketplace, including product development delays and defects. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements in this document may not occur.

WALCOM GROUP LTD
Date   Source Headline
30th Jun 20204:22 pmPRNBoard Change
22nd Jun 20201:21 pmRNSSuspension - Walcom Group Limited
22nd Jun 20201:16 pmPRNResignation of Nominated Adviser and Broker
22nd Jun 20208:16 amPRNCompany update
15th Jun 20207:36 amPRNTrading Update
5th Jun 20203:08 pmPRNCompany Update
2nd Jun 20204:00 pmPRNCompany update
29th May 20207:00 amPRNCompany Update
26th May 20207:32 amPRNCompany Update
15th May 20203:10 pmPRNCompany Update
11th May 202012:01 pmPRNCompany Update
30th Apr 202010:57 amPRNCompany Update
22nd Apr 202012:23 pmPRNCompany update and further re director loan
16th Apr 20201:31 pmPRNCompany update and further re director loan
9th Apr 20208:19 amPRNCompany update and further re director loan
3rd Apr 20208:27 amPRNCompany update and further re director loan
27th Mar 20208:31 amPRNCompany Update
18th Mar 20202:13 pmPRNCompany update and further re director loan
12th Mar 202010:46 amPRNCompany Update
6th Mar 20208:52 amPRNCompany Update
21st Feb 20208:48 amRNSCompany Update
14th Feb 202012:06 pmPRNReplacement: Company Update
14th Feb 202011:09 amPRNCompany Update
31st Jan 20209:55 amPRNTrading Update
13th Jan 202012:23 pmPRNFurther Director Loan
31st Dec 201910:37 amPRNCompany Update and Resignation of Deputy CFO
23rd Dec 20199:57 amPRNBoard Change
6th Dec 201911:04 amPRNCompany Update
29th Nov 201911:05 amPRNCompany Update
30th Oct 201910:23 amPRNTrading Update
26th Sep 20199:27 amPRNDirector Loan
18th Sep 201910:58 amPRNHalf-year Report
9th Sep 201911:20 amPRNCompany Update & Notice of Interim Results
14th Aug 201911:03 amPRNCompany Update
3rd Jul 201910:24 amPRNCompany update
12th Jun 20198:53 amPRNResult of AGM and update on legal proceedings
4th Jun 201912:49 pmPRNCompany update
15th May 201910:03 amPRNPosting of Annual Report and Notice of AGM
7th May 201911:15 amPRNFinal Results
20th Mar 20198:26 amPRNFurther re. disposal of Walcom Bio-Chem (Thailand)
13th Mar 20197:00 amPRNProposed Disposal of Walcom Bio-Chem (Thailand) Company
28th Feb 201910:10 amPRNDeath of Non-Executive Director
27th Feb 201911:44 amPRNTrading update
14th Dec 201811:06 amPRNBoard Change
21st Nov 201810:02 amPRNFurther re Customer Payment and Trading Update
8th Oct 20181:11 pmPRNReceipt of further customer payments
18th Sep 20181:58 pmPRNHalf-year Report
3rd Sep 201811:45 amPRNReceipt of initial customer payment
31st Jul 201811:38 amPRNFurther re Customer payment
19th Jul 201812:58 pmPRNFurther re Customer payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.